PTX in pole position as race to cure cancer heats up
Australian listed biotechnology company Prescient Therapeutics (ASX: PTX) today updated the market on progress on one of its personalised cancer...
News
Johnson & Johnson
News
The biggest breakthrough in cancer research since chemotherapy
Last month, the best and brightest minds in oncology gathered (virtually) for the American Society of Clinical Oncology (ASCO) annual...
News
COVID-19 drug sparks optimism in healthcare and the markets
As well as having infected in excess of 3.6 million and claimed 250,000 lives, COVID-19 has put the global economy...